Epidermal growth factor receptor (EGFR) mutations are observed in approximately 10-15% of the Caucasian population 1 and more than 50% of the Asian population 2 with non-squamous non-small cell lung cancer (NSCLC). This evidence concerns the gene EGFR and non-small cell lung carcinoma.